{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:38:35Z","timestamp":1793320715162,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341088"],"award-info":[{"award-number":["82341088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22377143"],"award-info":[{"award-number":["22377143"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2303100"],"award-info":[{"award-number":["2022YFC2303100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2300700"],"award-info":[{"award-number":["2021YFC2300700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2308000"],"award-info":[{"award-number":["2023YFC2308000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejmech.2024.116299","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T14:53:03Z","timestamp":1709909583000},"page":"116299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Improving Anti-HIV activity and pharmacokinetics of enfuvirtide (T20) by modification with oligomannose"],"prefix":"10.1016","volume":"269","author":[{"given":"Shuihong","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116299_bib1","series-title":"UNAIDS Global AIDS Update 2022","author":"Unaids","year":"2022"},{"key":"10.1016\/j.ejmech.2024.116299_bib2","unstructured":"FDA website, Antiretroviral drugs used in the treatment of HIV infection. (accessed on 12 April 2018); Available online: https:\/\/www.fda.gov\/."},{"key":"10.1016\/j.ejmech.2024.116299_bib3","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acs.jmedchem.5b00497","article-title":"Anti-HIV drug discovery and development: current innovations and future trends","volume":"59","author":"Zhan","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116299_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Viral Activation Transfusion Study Investigators, Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease","volume":"135","author":"Murphy","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejmech.2024.116299_bib5","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.116299_bib6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ni841","article-title":"Diversity of receptors binding HIV on dendritic cell subsets","volume":"3","author":"Turville","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2024.116299_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2003.09.028","article-title":"Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission","volume":"318","author":"Wu","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.ejmech.2024.116299_bib8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80694-7","article-title":"DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.116299_bib9","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1172\/JCI119737","article-title":"Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways","volume":"100","author":"Blauvelt","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2024.116299_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1126\/science.1352913","article-title":"Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells","volume":"257","author":"Cameron","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116299_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/cb900216e","article-title":"Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation","volume":"5","author":"Sattin","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116299_bib12","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/cbic.200900294","article-title":"Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cell","volume":"10","author":"Mart\u00ednez-Avila","year":"2009","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2024.116299_bib13","doi-asserted-by":"crossref","first-page":"7434","DOI":"10.1002\/chem.200800597","article-title":"Interfering with the sugar code: design and synthesis of oligosaccharide mimics","volume":"14","author":"Bernardi","year":"2008","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2024.116299_bib14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1017\/S0007114508025804","article-title":"Human milk oligosaccharides reduce HIV-1-gp120 binding to dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN)","volume":"101","author":"Hong","year":"2008","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ejmech.2024.116299_bib15","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1172\/JCI25105","article-title":"Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes","volume":"115","author":"Naarding","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2024.116299_bib16","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1074\/jbc.RA119.007360","article-title":"HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry","volume":"294","author":"Eggink","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116299_bib17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00002030-200303280-00007","article-title":"A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy","volume":"17","author":"Lalezari","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.ejmech.2024.116299_bib18","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.biocel.2008.08.039","article-title":"Electrostatically constrained alpha-helical peptide inhibits replication of HIV1 resistant to enfuvirtide","volume":"4","author":"Nishikawa","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.116299_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00726-005-0289-3","article-title":"Strategies to improve plasma half life time of peptide and protein drugs","volume":"30","author":"Werle","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejmech.2024.116299_bib20","doi-asserted-by":"crossref","first-page":"11126","DOI":"10.1074\/jbc.M800200200","article-title":"Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor","volume":"283","author":"He","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116299_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00386-20","article-title":"Polyethylene glycol 40-modified peptide with high therapeutic efficacy in simian-human immunodeficiency virus-acutely infected rhesus monkeys","volume":"94","author":"Li","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2024.116299_bib22","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1021\/jm5016582","article-title":"Glycosylated enfuvirtide: a long-lasting glycopeptide with potent anti-HIV activity","volume":"58","author":"Cheng","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116299_bib23","doi-asserted-by":"crossref","first-page":"17033","DOI":"10.1073\/pnas.0407902101","article-title":"Printed covalent glycan array for ligand profiling of diverse glycan binding proteins","volume":"101","author":"Blixt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2024.116299_bib24","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1126\/science.1066371","article-title":"Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR","volume":"294","author":"Feinberg","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116299_bib25","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1074\/jbc.M609689200","article-title":"Multiple modes of binding enhance the affinity of DC-SIGN for high mannose N-linked glycans found on viral glycoproteins","volume":"282","author":"Feinberg","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116299_bib26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejmech.2016.05.027","article-title":"Enfuvirtide-PEG conjugate: a potent HIV fusion inhibitor with improved pharmacokinetic properties","volume":"121","author":"Cheng","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116299_bib27","doi-asserted-by":"crossref","first-page":"9809","DOI":"10.1021\/jo051503w","article-title":"Investigation of nonspecific effects of different dyes in the screening of labeled carbohydrates against immobilized proteins","volume":"70","author":"Dowlut","year":"2005","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.116299_bib28","doi-asserted-by":"crossref","first-page":"7695","DOI":"10.1002\/anie.200903328","article-title":"DNA-templated homo- and heterodimerization of peptide nucleic acid encoded oligosaccharides that mimick the carbohydrate epitope of HIV","volume":"48","author":"Gorska","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2024.116299_bib29","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1074\/jbc.M609148200","article-title":"HIV gp41 C-terminal heptad repeat contains multifunctional domains: relation to mechanisms of action of anti-HIV peptides","volume":"282","author":"Liu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116299_bib30","doi-asserted-by":"crossref","first-page":"30376","DOI":"10.1074\/jbc.M804672200","article-title":"Rationally designed anti-HIV peptides containing multifunctional domains as molecule probes for studying the mechanisms of action of the first and second generation HIV fusion inhibitors","volume":"283","author":"Qi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116299_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116299_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1743-422X-8-230","article-title":"Inhibitory activity of 9-phenylcyclohepta[d]pyrimidinedione derivatives against different strains of HIV-1 as non-nucleoside reverse transcriptase inhibitors","volume":"8","author":"Huang","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.ejmech.2024.116299_bib33","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1128\/JVI.00435-10","article-title":"Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins","volume":"84","author":"Morizono","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2024.116299_bib34","first-page":"1942","article-title":"Construction of HIV-1 B subtype pseudovirus system in Guangxi","volume":"34","author":"Huang","year":"2018","journal-title":"Journal of Practical Medicine"},{"key":"10.1016\/j.ejmech.2024.116299_bib35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejmech.2014.01.047","article-title":"Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor","volume":"75","author":"Toma\u0161i\u0107","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116299_bib36","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.3390\/ijms21155290","article-title":"TETRALEC, artificial tetrameric lectins: a tool to screen ligand and pathogen interactions","volume":"21","author":"Achilli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116299_bib37","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1128\/AAC.48.11.4349-4359.2004","article-title":"N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion","volume":"48","author":"Jiang","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116299_bib38","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.1128\/JVI.76.20.10299-10306.2002","article-title":"Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1","volume":"76","author":"Lue","year":"2002","journal-title":"J. Virol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342400179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342400179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:59:43Z","timestamp":1759330783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342400179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":38,"alternative-id":["S022352342400179X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116299","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving Anti-HIV activity and pharmacokinetics of enfuvirtide (T20) by modification with oligomannose","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116299"}}